CELLEGY PHARMACEUTICALS INC 4
4 · CELLEGY PHARMACEUTICALS INC · Filed Oct 26, 2004
Insider Transaction Report
Form 4
KARLIN DAVID A
VP, Clinical Research
Transactions
- Sale
Common Stock
2004-10-22$5.00/sh−2,400$12,000→ 12,600 total - Sale
Common Stock
2004-10-22$5.02/sh−100$502→ 12,500 total